NCT00770575 - Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease | Biotech Hunter

Enrollment

148

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Cardiovascular Diseases

Interventions

DRUG

Pioglitazone and atorvastatin

"Pioglitazone 30 mg, capsules, orally, once daily and atorvastatin 20 mg, tablets, orally, once daily for 4 weeks; increase to:~Pioglitazone 45 mg, capsules, orally, once daily and atorvastatin 40 mg, tablets, orally, once daily for up to 20 weeks."

DRUG

Atorvastatin

"Pioglitazone placebo-matching capsules, orally, once daily and atorvastatin 20 mg, tablets, orally, once daily for 4 weeks; increased to~Pioglitazone placebo-matching capsules, orally, once daily and atorvastatin 40 mg, tablets, orally, once daily for up to 20 weeks."